JPRN-jRCT1031200022招募中2 期
The effect and safety of dulaglutide for hyperglycemia associated with R-CHOP thepapy
Suyama Takuya0 个研究点目标入组 10 人开始时间: 2020年4月27日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Patients recieved R-CHOP therapy for malignant lymphoma
- •(2) ECOG performance status score 0-2
- •(3) Patients dignosed with Type2 diabetes, or Patients who have been found twice by repeated tests of either fasting blood glucose of 126 mg / dl or more and blood glucose of 200 mg / dl or more during first chemotherapy
- •(4) Patients who are not allergic to dulaglutide
- •(5) Patients who have never used duraglutide before
- •(6) Patients with written consent
排除标准
- •(1) Patients with a history of hyperglycemic coma and diabetic ketoacidosis
- •(2) Patients with type 1 diabetes
- •(3) Patients judged by the researcher to be inappropriate as subjects
研究者
相似试验
招募中
不适用
Efficacy and safety of dulaglutide in the treatment of type 2 diabetesType 2 diabetes mellitus patientsJPRN-UMIN000027255Department of nephrology, Matsunami general hospital30
已完成
不适用
Safety and efficacy of dulaglutide therapy for the inpatient management of general medicine patients with type 2 diabetesType 2 diabetesJPRN-UMIN000025006Ichinomiyanishi hospital40
已完成
4 期
The efficacy of dulaglutide in diabetic patientsType2 diabetic patientsJPRN-UMIN000019975Kawashima Hospital50
已完成
不适用
Efficacy and safety of dulaglutide when used instead of exenatide extended-release in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000019031Haga Diabetes Clinic40
已完成
不适用
Efficacy and safety of dulaglutide when used instead of sitagliptin in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000023245Iwasaki Naika Clinic40